BARCELONA, Spain—New guidelines for the diagnosis and treatment of pulmonary hypertension (PH), released at the recent European Society of Cardiology (ESC) Congress 2022, include a new hemodynamic ...

This transcript has been edited for clarity. Vallerie McLaughlin, MD: Hello. I'm Dr. Vallerie McLaughlin from the University of Michigan. And welcome to this edition of Medscape InDiscussion series on ...

Please provide your email address to receive an email when new articles are posted on . The updated European Society of Cardiology risk assessment tool accurately estimated mortality risk among ...

Earlier detection of pulmonary hypertension in the community and expedited referral of high-risk or complex patients are recommended in the European Society of Cardiology (ESC) and European ...

Earlier detection of pulmonary hypertension in the community and expedited referral of high-risk or complex patients are recommended in the European Society of Cardiology (ESC) and European ...

New European Society of Cardiology (ESC)/European Respiratory Society (ERS) guidelines for diagnosis and treatment of pulmonary hypertension have lowered the cutoff for defining pulmonary hypertension ...

The REVEAL scores were superior to the ESC/ERS risk 2022 score and the COMPERA registry 3-strata risk score in predicting PH survival. Risk stratification scoring systems designed for pulmonary ...

Please provide your email address to receive an email when new articles are posted on . In patients with pulmonary arterial hypertension, many initially receive just one drug of the combination ...

At Janssen, our mission is to put the needs and well-being of the people we serve as a top priority. As part of the larger healthcare ecosystem, we also recognize our responsibility to listen to and ...

BACKGROUND: BCR-ABL tyrosine kinase inhibitors (TKIs) have been increasingly linked to pulmonary arterial hypertension (PAH) since 2009, although supporting evidence is limited. Our objective was to ...

The guidance moves away from advising women with rare health conditions that make their pregnancy high-risk, (such as vascular Ehlers-Danlos syndrome and pulmonary arterial hypertension), against ...